French-headquartered dairy giant Danone said today that in accordance with its focus on capital allocation discipline and balance sheet strength, the company is selling its 6.61% stake in the Japanese company Yakult Honsha Co. Ltd.
Chr. Hansen is to acquire Jennewein Biotechnologie for €310m in a deal designed to merge the bioscience firm’s probiotic interests with the gains Jennewein have made in the Human Milk Oligosaccharides (HMO) market.
Swisse and Biostime owner Health and Happiness (H&H) Group saw demand for immunity products surge, especially in China, as it announced an 8.9% increase in net profit in the first half of this year, despite seeing revenues in Australia and New Zealand...
New legislation including ban on TV advertisements for HFSS food before 9pm – and a complete ban on online adverts - is being considered by ministers as study reveals fresh evidence between obesity and risk of catching COVID-19.
Danone China has launched two new products for its Aptamil Essensis 3 range, including an A2 milk and a formula said to contain the highest level of human oligosaccharides (HMOs) across the firm’s entire early life nutrition portfolio.
India is leading the APAC market with the highest number of new food, drinks and supplements that bear immune system-boosting claims launched in the last five months. Australia and Indonesia ranked second and third.
Mycoprotein, the mushroom derived protein source found in meat replacement products, stimulates muscle growth better than a leucine-matched portion of milk protein, according to a new study in resistance trained men.
Demand for functional dairy ingredients has never been higher. This is largely driven by the high-protein trend – consumers increasingly understand the proven benefits of high-quality proteins, in particular those from whey, for muscle growth, weight...
Human Milk Oligosaccharides (HMO) such as 2’-fucosyllactose (2’-FL), and galactooligosaccharides (GOS) that are added to infant formula may offer protection against bacterium known to cause tooth decay.
Regulators from China and importing countries should cooperate to arrest the problem of milk formula not intended for infant consumption being marketed as such in the China market, said an industry observer.